N9 WORLD TECHNOLOGIES & CONSOLIDATED PATHWAYS INTRODUCE VIROBAN – SWISS ANTIVIRAL AND ANTIMICROBIAL TECHNOLOGY

N9 World Technologies Pvt Ltd, India has signed an agreement with Consolidated Pathways Inc, USA to incorporate unique Swiss antiviral and antimicrobial technologies into sustainable and cost-effective custom blends for the textile finishing industry.

- Surabhi Khosla

Consolidated Pathways, a brand and technical representative for Sanitised products, supports the advancement of the trusted Sanitised Quality Seal and related branding concepts to the global textile industry.

With this partnership, N9 is utilising USEPA and EU BPR registered Antimicrobials in its antibacterial and antiviral custom blends. Now N9’s special offering, VIROBAN will provide antiviral performance bringing proven hygiene function and much-needed material protection to the textile industry.

Focusing on this momentous importance of the partnership, the discussion offered a preview of the new textile finishing products N9 will be launching, with special emphasis on their differential sustainability and performance, and also on how these products will add tremendous value to the global textile industry. The discussion was moderated by Surabhi Khosla, Managing Editor, IMAGES Group.

The panelists include:

• Vikram D Rao, MD, N9 World Technologies

• Ganesh Srinivasan, CEO, Resil Chemicals

• James W. (Jim) Krueger, CEO, Consolidated Pathways

• Dr Robert A. (Bob) Monticello, President, Consolidated Pathways

• Manish Khambe, Head of Business Development, N9 World Technologies

• Prem Sadhwani, Business Development Director, Consolidated Pathways

Excerpts from the discussion: